Big Tech is investing billions in fusion power startups like Shine Technologies, a Nucleation portfolio company, driven by recent breakthroughs and the vision of a clean energy future...
SHINE Technologies, a Nucleation portfolio venture and next-generation fusion company, today announced a strategic partnership with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company. The partnership, formalized through a Memorandum of Understanding (MOU), will explore and develop pathways for SCOA to promote and distribute SHINE's innovative products and services throughout Japan and other Asian markets.
Published by Nucleation Capital in Advanced Nuclear, Advanced Nuclear Customers, Fusion, International Collaboration, INTERNATIONAL NEWS, Medical Isotopes, Neutron services, NEWS, Nuclear waste, Portfolio Venture, Private companies
SHINE Technologies – A Wisconsin-based developer of fusion energy, commercializing in the interim their high flux neutrons from DT fusion for radiation effects testing, isotope production and waste separation enroute to development of cost-effective fusion energy, producing Ilumira, a potent cancer therapy, made from Lutetium-177.
Published by Nuclea_Admin in PORTFOLIO
Sign up to receive Nucleation Insights
For Current Investors
(Note: Must be logged in at AngelList)
Nucleation Direct Messages
Nucleation (Fund I) Posts
Your Portfolio Dashboard
Your Funding Page
How to Contact Us
© 2025 Nucleation Capital | Terms & Policies
